HUM vs XPER · P/E 39, rev $117.76B vs rev $493.7M
Humana Inc (HUM) versus Xperi Corp (XPER) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Xperi Corp (XPER) is a software - application company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported XPER revenue for 2024-12-31 was $493.7M. Net income was -$869.0K. Revenue was down 5.3% from 2023-12-31 to 2024-12-31. XPER currently screens at market cap $367.8M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. XPER currently screens at market cap $367.8M.
Not investment advice. Open the HUM and XPER stock pages for the full models.
Not investment advice.